InnoCare Doses First Patient in Mesutoclax BCL2 Inhibitor Trial for MCL in China
InnoCare Pharma has dosed the first patient in a registrational trial of its BCL2 inhibitor, mesutoclax (ICP-248), for mantle...
Global Knee Replacement Surgery Market to Surpass $16B by 2030
The global knee replacement surgery market is projected to reach $16.17 billion by 2030, expanding at a 6.1% compound...
Septerna Doses First Participants in Sep-631 Phase 1 Trial
Septerna has dosed the first participants in a Phase 1 trial of SEP-631, an oral, selective, small molecule Mas-related...
Evoke Pharma Gimoti Patent Listed in FDA Orange Book
Evoke Pharma has secured a new U.S. patent (No. 12,377,064) for the use of its GIMOTI (metoclopramide) nasal spray...
Chinese Team Enables 24 Type 1 Diabetics to Stop Insulin
A Shenzhen-based medical team reports that 24 patients with Type 1 diabetes (T1DM) have discontinued insulin therapy following treatment...
How Sponsors Can Win or Lose in the 510(k) Strategy Pathway
The start-up team was confident. Their Class II device had promising bench data, strong engineering, and investors eager for...
Chinese Team Enables 24 Patients to Stop Insulin Use: Breakthrough in Type 1 Diabetes Treatment
A Shenzhen-based medical team reports that 24 patients with Type 1 diabetes (T1DM) have discontinued insulin therapy, achieving a...
Nurexone Biologic Shows Preclinical Spinal Cord Repair with Exopten
NurExone Biologic Inc. has released new preclinical MRI-DTI (Diffusion Tensor Imaging) data for ExoPTEN, its exosome-based therapy for spinal...
Hutchmed Completes Patient Enrollment for Orpathys®-Tagrisso® Lung Cancer Trial in China
Hutchmed has completed enrollment in its China Phase 3 SANOVO trial, evaluating the combination of savolitinib (Orpathys) and osimertinib...
Hutchmed Enrolls First-Line Lung Cancer Patients in China Trial
HUTCHMED has completed enrollment in its China Phase III SANOVO trial evaluating savolitinib plus osimertinib as a first-line treatment...